CLINICAL TRIALS PROFILE FOR CEFDINIR
✉ Email this page to a colleague
All Clinical Trials for cefdinir
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00147914 ↗ | Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life | Completed | University of Chicago | Phase 4 | 2005-02-01 | This study is a comparison between two commonly used antibiotics (Cefdinir vs. Amoxicillin/Clavulanate) in patients with acute sinus infection, surveying quality of life. The hypothesis is that the two treatments would be at the least equivalent based on clinical outcome measures of improvement in quality of life. |
| NCT00234949 ↗ | A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections | Completed | Abbott | Phase 4 | 2005-03-01 | The purpose of this study is to compare the efficacy and tolerability of cefdinir to that of cephalexin in patients with mild to moderate uncomplicated skin/skin structure infections. |
| NCT00644774 ↗ | A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications | Completed | Abbott | Phase 4 | 2003-01-01 | To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication. |
| NCT00644891 ↗ | Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications | Completed | Abbott | Phase 4 | 2003-01-01 | To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It was designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell. |
| NCT00644943 ↗ | A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media | Completed | Abbott | Phase 4 | 2003-02-01 | The primary objective is to compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg/day ql2hrs for 5 days, to amoxicillin/clavulanate oral suspension 45 mg/kg/day (based on amoxicillin component), in divided doses, q12h for 10 days, in children between 6 months and 6 years of age, with AOM. |
| NCT00645073 ↗ | Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis | Completed | Abbott | Phase 4 | 2003-11-01 | To compare the safety and efficacy of a ten-day course of therapy of cefdinir, 600 mg QD, to a ten-day course of therapy of levofloxacin, 500 mg QD, in the treatment of acute bacterial sinusitis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for cefdinir
Condition Name
Clinical Trial Locations for cefdinir
Trials by Country
Clinical Trial Progress for cefdinir
Clinical Trial Phase
Clinical Trial Sponsors for cefdinir
Sponsor Name
